16-5033896-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016256.4(NAGPA):c.19C>A(p.Arg7Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000286 in 1,396,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016256.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAGPA | NM_016256.4 | c.19C>A | p.Arg7Ser | missense_variant | 1/10 | ENST00000312251.8 | NP_057340.2 | |
NAGPA-AS1 | NR_038913.1 | n.195G>T | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAGPA | ENST00000312251.8 | c.19C>A | p.Arg7Ser | missense_variant | 1/10 | 1 | NM_016256.4 | ENSP00000310998 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000646 AC: 1AN: 154684Hom.: 0 AF XY: 0.0000122 AC XY: 1AN XY: 81810
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1396876Hom.: 0 Cov.: 34 AF XY: 0.00000581 AC XY: 4AN XY: 688938
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.19C>A (p.R7S) alteration is located in exon 1 (coding exon 1) of the NAGPA gene. This alteration results from a C to A substitution at nucleotide position 19, causing the arginine (R) at amino acid position 7 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at